Thomas Seck

Equibles does not estimate personal net worth.

About Thomas Seck

Thomas Seck has spoken on 1 investor event across 1 company, most recently for ELI LILLY & Co on June 6, 2026. ELI LILLY & Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at ELI LILLY & Co includes Juan Luciano (CEO), David Ricks (Chairman and Board Member), Kimberly Johnson (COO) and 6 others.

Thomas Seck on recent calls

“Let's move, because I don't have much time, let's move right away to the Fondeo development program. As Ken mentioned, there are seven registration studies that have been completed.”

Other, Lilly Investor Event at American Diabetes Association's (ADA) 86th Scientific Sessions · June 6, 2026